To address whether the burst of systemic interleukin-12 (IL-12) influences intestinal inflammation elicited by luminal stimuli, we induced IL-12 release by cDNA injection in C57BL/6 mice and simultaneously started dextran sulphate sodium administration. The sequence of the inflammatory response triggered by IL-12 release was characterized by assessing myeloperoxidase activity and histological damage in colon samples on days 1, 3, 5 and 7 after colitis induction. To evaluate the persistence of IL-12 priming, colitis was induced in mice 7 or 60 days after cDNA injection. Under IL-12 influence, the development of acute colitis presented a faster and selective infiltration of inflammatory mononuclear cells in the lamina propria. Recruitment was driven by systemic cytokines rather than luminal antigens. Interestingly, when colitis was triggered 7 or 60 days after the cytokine storm, cells maintained the ability to worsen clinical signs of intestinal inflammation. Together, a systemic IL-12 burst effectively primed intestinal cells that became more prone to develop inflammatory responses. Activation was long-lasting because intestinal cells maintained their inflammatory potential and their ability to aggravate colitis.
Introduction
Inappropriate recruitment and accumulation of leucocytes in the gut seem pivotal in inflammatory bowel disease. 1 Animal models are valuable tools to understand the sequence of inflammation and characterize mediators of intestinal injury. 2 The most widely used model of colitis in mice uses dextran sulphate sodium (DSS) to induce the disease. The DSS breaks the epithelial barrier, allowing the entry of luminal antigens and microorganisms into the mucosa resulting in overwhelming inflammation. 3 Models of acute, chronic and relapsing intestinal inflammation can be developed by changing DSS concentration and the administration schedule. 4 Acute colitis develops by continuous administration of 2-5% DSS for 4-9 days; clinical signs usually start after 1 day of treatment with increased intestinal permeability, diarrhoea, occult blood in stools, weight loss, anaemia and, depending on the experimental procedure, mortality. 4, 5 Typically, an influx of neutrophils occurs into the lamina propria (LP) and the submucosa, which correlates with myeloperoxidase (MPO) activity in the colonic tissue. Apparently, the adaptive immune system does not play a major role in the acute model because T-cell-deficient and B-celldeficient mice also develop severe intestinal inflammation. 6 Histological changes observed after DSS administration include mucin depletion, ulceration and submucosal inflammation, epithelial barrier disruption, neutrophil infiltration in the LP and submucosa, and abscesses. 4, 5 Interleukin-12 (IL-12) is a master regulator of innate and adaptive immune responses against pathogens and tumours 7 due to its ability to drive T helper type 1 (Th1) responses. 8 Hence, systemic IL-12 that is released during infections or in clinical applications could affect intestinal Abbreviations: DAI, Disease Activity Index; DC, dendritic cell; DSS, dextran sulphate sodium; h.i., hydrodynamic injection; IFNc, interferon-c; IL, interleukin; LP, lamina propria; MLN, mesenteric lymph nodes; MPO, myeloperoxidase; STAT, signal transducer and activator of transcription; Th1, T helper type 1; TNF-a, tumour necrosis factor-a 
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homeostasis. In fact, the gut can be the target of IL-12 biological activity 9, 10 because mice lacking the IL-12p40 gene, a common subunit of IL-12 (a Th1 trigger) and IL-23 (a Th17 trigger) cytokines, develop attenuated colitis. 11 In the same way, mice treated with neutralizing antibodies against IL-12p40 develop milder colitis, 12, 13 which emphasizes the key contribution of Th1/Th17 cell responses in intestinal inflammation.
14 Also, repeated doses of IL-12 alone or combined with other cytokines produce detrimental effects in BALB/c mice with mucosal damage, bloody diarrhoea and weight loss, 15 and they drive a chronic inflammation in DSS-induced colitis. 13 Despite these reports, the influence of systemic IL-12 in intestinal immunity has not yet been fully understood. After hydrodynamic injection (h.i.) of IL-12 cDNA in C57BL/6 mice, we found that T lymphocytes from Peyer's patches and mesenteric lymph nodes (MLN) become activated, exhibit a CD44 hi CD62L À phenotype and up-regulate the a 4 b 7 integrin expression. 16 The increased a 4 b 7 expression depends on the axis formed by the IL-12 receptor and the signal transducer and activator of transcription 4 (STAT-4) and occurs independently of interferon-c (IFN-c), IL-4, IL-10 and tumour necrosis factor-a (TNF-a) signalling. 16 Mice injected with IL-12 cDNA do not develop intestinal inflammation; nonetheless, upon DSS administration, acute colitis shows higher severity. 16 To further characterize the effect of systemic IL-12, we evaluated the sequence of inflammatory response under IL-12 influence and the persistence of IL-12 priming away from the primary cytokine burst. This study shows that systemic IL-12 endowed intestinal mononuclear cells with inflammatory potential. This ability exacerbated the inflammatory response to luminal stimulation away from the initial burst of IL-12.
Materials and methods

Ethical considerations
All animal experiments were approved by and conducted in accordance with the guidelines of the Committee for Animal Care and Use of the Facultad de Ciencias Qu ımi-cas, Universidad Nacional de C ordoba (Approval Number HCD 15-09-69596), and in strict conformity with the recommendation of the Guide to the Care and Use of Experimental Animals published by the Canadian Council on Animal Care (OLAW Assurance number A5802-01). Our animal facility obtained the NIH Animal Welfare Assurance (Assurance No. A5802-01, Office of Laboratory Animal Welfare, NIH, Bethesda, MD).
Mice
Six-to eight-week-old C57BL/6 (B6) mice from the Jackson Laboratory (Bar Harbor, ME) were used in these studies. The animals were maintained in specific pathogen-free conditions and housed in collective cages at 22 AE 1°under a 12-hr light/dark cycle (lights on at 7:00 a.m.) with free access to laboratory chow and drinking water.
Reagents and antibodies
The IL-12 plasmid was kindly provided by Dr Howard Young (Frederick National Laboratory for Cancer Research, Frederick, MD). The DSS (MW 40 000) was a kind gift from George Usher, Dextran Products Limited (Scarborough, ON, Canada). Anti-CD3 (17A2), anti-CD28 (37.51), anti-CD4 (GK 1.5), anti-CD8 (53-6.7), anti-CD11b (M1/70), anti-MHC-II (25-9-17), CD11c (HL3) and anti-CCR5 (C34-3448) were provided by BD PharMingen (San Diego, CA); and CD103 (2E7) and anti Ly6C (HK.1.4) by BioLegend (San Diego, CA). Corresponding isotype-matched monoclonal antibodies were used as controls in flow cytometry experiments. Recombinant murine IL-12p70 (210-12) was from Peprotech (Colonia Narvarte, Mexico).
Hydrodynamic cDNA injection
The hydrodynamic gene transfer procedure was described previously. 16 Expression plasmids use the human elongation 1-a promoter to drive transcription. The animals were given an h.i. with 0Á5 lg open reading frame empty vector control cDNA or pscIL-12 cDNA (p40-p35 fusion gene) in the tail vein in 1Á6 ml of sterile 0Á9% sodium chloride solution in 5-7 seconds. The marked splenomegaly observed on day 7 or at the end of each experiment confirmed the effectiveness of the treatment, as previously reported. [16] [17] [18] For transfer experiments, MLN cells from IL-12 or the control cDNA-injected mice were isolated 7 days after h.i., cultured with 50 ng/ml recombinant IL-12 (rIL-12) for 16 hr and injected (2Á5 9 10 6 cells) intravenously in C57BL/6 mice. On the same day, administration of DSS was started for colitis induction, as detailed below.
Induction and assessment of DSS colitis
The mice were given a solution of filtered water containing 3% (weight/volume) DSS (MW 40 000) ad libitum over a 5-day period. Every other day, the DSS solution was replenished and at the end of this period it was replaced with normal drinking water for 2 days. The control mice received only normal drinking water. All the animals were examined once a day and the Disease Activity Index (DAI) that combines scores of weight loss, stool consistency and bleeding was assessed as previously described. 19 Briefly, for weight loss, a value of 0 was assigned if body weight increased or remained within 1% of baseline, 1 for a 1-5% loss, 2 for a 5-10% loss, 3 for a 10-15% loss, and 4 for weight loss > 15%. For stool consistency, a value of 0 was for no diarrhoea, 2 for loose stools that did not stick to the anus and 4 for liquid stools that did stick to the anus. For faecal blood, 0 was for none, 2 for moderate and 4 for gross bleeding. When indicated, blood samples were taken from the tail vein and centrifuged immediately; sera were frozen for further analysis. 20 The animals were killed by cervical dislocation; their colons were removed and examined for weight, macroscopic appearance and length (which was measured from 1 cm above the anus to the top of the caecum).
Myeloperoxidase assay
Neutrophil infiltration into the colon was assessed indirectly by measuring MPO activity as previously explained. 19 The colon segments were homogenized in 5% EDTA/NaCl buffer (pH 4Á7) and centrifuged at 10 000 g for 15 min at 4°. The pellets were resuspended in 0Á5% hexadecyl trimethyl ammonium bromide buffer (pH 5Á4), and the samples were frozen in liquid nitrogen and thawed three times. After the final thawing, they were centrifuged as above, and 25 ll of the supernatant was used for MPO assay. The MPO enzymatic reaction was assessed by adding 1Á6 mmol/l tetramethylbenzidine, 80 mmol/l NaPO 4 and 0Á3 mmol/l H 2 O 2 . The absorbance was measured spectrophotometrically at 690 nm and MPO was calculated with a standard curve generated for each experiment. The results were expressed as nanograms per milligram of tissue.
Histopathological analysis
The excised portions of the distal colon were immediately fixed in 4% (weight/volume) formaldehyde solution and embedded in paraffin. Next, 5-lm sections were mounted on glass slides, deparaffinized and stained using standard haematoxylin & eosin techniques. For histological analysis we used the histological score that represents the sum of histoarchitecture alterations, mononuclear and polymorphonuclear infiltrates in the epithelium, LP and submucosa, crypt alterations, pseudopolyp formation, oedema and ulcers, as described by Geboes et al. 21, 22 Images were taken with a Nikon optical microscope (Nikon Eclipse TE2000-U, Melville, USA.).
Explant cultures and cell isolation
Extraintestinal fat tissue and blood vessels were carefully removed; large intestines were flushed with RPMI-1640 and opened along a longitudinal axis. Then, 5-mm 2 punch biopsies were obtained from the medial colon and incubated for 24 hr in RPMI-1640 supplemented with 10% fetal calf serum and antibiotics (one punch biopsy per 1 ml medium). Supernatants were collected and kept at À20°until the production of cytokines was assessed as explained above.
Colonic LP cells were isolated as follows. 23 The colon was cut into small pieces and epithelial cells and mucus were removed by 45-min incubation with RPMI-1640 containing 5% fetal bovine serum, 2 mM EDTA and 1 mM dithiothreitol (Sigma, St Louis, MO) at 37°with 250 rpm shaking. The colon pieces were then digested in PBS containing 5% fetal bovine seurm and 1 mg/ml collagenase IV (Sigma) for 90 min at 37°and shaken at 250 rpm. The digested cell suspension was washed with PBS and passed through 40-lm cell strainers.
Cell culture
The MLN single-cell suspensions (1 9 10 6 cells/ml) were cultured with medium, 2 lg/ml anti-CD3/1 lg/ml anti-CD28 antibodies or 50 ng/ml rIL-12. When indicated, supernatants were harvested 24 hr later and assayed for cytokines as described below.
Measurement of cytokines and chemokines
Murine monocyte chemoattractant protein 1 (MCP-1) and IL-1b (BD Biosciences, San Jos e, CA.) or IFN-c, IL-6 and IL-10 (BD Pharmingen) were measured in sera or culture supernatants by ELISA kits, as specified by the manufacturers.
Flow cytometry
The cells were stained with the desired antibodies and, on the basis of forward and side light scatter, debris and dead cells were gated out; 10 000 events were analysed using a FACSAria flow cytometer (BD Bioscience). The flow cytometry analysis was performed with the FLOWJO software (Treestar, Ashland, OR, USA).
Statistical analysis
Data were expressed as mean AE SD. Statistical differences between groups were determined by a one-way analysis of variance followed by a Student-Newman-Keuls test. Statistical analyses were performed using GRAPHPAD PRISM 4 software (GraphPad Software, San Diego, CA). A P value of < 0Á05 was considered statistically significant. IL-12 influence, the typical increase of MPO activity on day 7 does not occur. 16 To address whether neutrophil infiltration could have occurred earlier in this experimental condition, mice were given h.i. with IL-12 cDNA and treated with DSS as described above. 16 The DAI was calculated daily, and colon length and MPO activity were assessed on days 1, 3, 5 and 7 of the treatment in representative mice from the control, IL-12, DSS and IL-12+DSS groups. As already stated, the combined treatment resulted in a higher DAI as early as day 4 (Fig. 1a) and in a significantly shortened colon length on day 5 (Fig. 1b) . The progressive increase in MPO activity observed in acute DSS colitis from days 1 to 7 was not detected in the IL-12+DSS group (Fig. 1c) , suggesting that IL-12 could be driving a different inflammatory response. To confirm the reduced neutrophil influx under IL-12 influence, we characterized the histopathological damage in the colon sections on days 1, 3, 5 and 7 after DSS administration. Representative microphotographs show that colon integrity was maintained on day 1 (Fig. 2a ,e,i,m), although all groups had a moderate presence of inflammatory cells associated with the hydrodynamic process. [16] [17] [18] On day 3, the histological features of the control and IL-12 groups were normal (Fig. 2b,f) , whereas colon damage started in the DSS group with oedema, inflammatory infiltrate and crypt alterations (Fig. 2j) . On that day, IL-12+DSS mice presented more ulcers, a larger amount of mononuclear cells in the LP and epithelium, and severe crypt alterations (Fig. 2n) . Changes observed in DSS-treated mice on day 5 were similar to those in the IL-12+DSS group as early as day 3 ( Fig. 2k versus n) , which reached a critical grade of colitis on day 7 with a marked infiltrate of polymorphonuclear cells (Fig. 2l) . On that day, animals from the IL-12+DSS group showed mild to moderate oedema, ulcers and a considerable amount of mononuclear cells (Fig. 2p) . The combined IL-12+DSS treatment induced injury and colon inflammation earlier on day 3, with a slight amelioration by day 7. In contrast, mice receiving only DSS reached the highest histopathological index by day 7. Table S1 (see Supplementary material) provides the detailed score that includes mononuclear and polymorphonuclear infiltrates (in the epithelium, LP and submucosa), crypt alterations, oedema and ulcers from each group calculated as described elsewhere 21, 22 ; the mean histological score is shown in Fig. S1 (see Supplementary material).
Results
Systemic
To correlate the histopathological analysis with the ongoing systemic inflammation, we measured serum cytokines in all experimental groups on days 1, 3, 5 and 7 (see Supplementary material, Fig. S2a ). Mice from the IL-12 group produced more TNF-a, IFN-c and IL-10 than the DSS group with an ongoing inflammatory response in the colon. Interestingly, the luminal stimuli were unable to expand serum cytokines over the values triggered by IL-12 alone (i.e. IL-12 versus IL-12+DSS). The MLN cell suspensions stimulated with rIL-12 or aCD3/aCD28 antibodies from both groups injected with IL-12 cDNA produced higher levels of IFN-c, which demonstrated that IL-12 was driving the Th1 response in mucosal lymphoid tissue during intestinal inflammation (see Supplementary material, Fig. S2b ). On the other hand, the animals IL-12) influence. The C57BL/6 mice (6-8 weeks old) were given a hydrodynamic injection (h.i.) with the control or IL-12 cDNAs; on the same day, they were administered DSS in drinking water. The mice were evaluated daily to calculate the Disease Activity Index (DAI) (a). Representative animals from each group were killed on days 1, 3, 5 or 7 and colon segments were removed to assess colon length (b) and myeloperoxidase (MPO) activity (c). Data are mean AE SD of two different experiments with three mice per group. *P < 0Á05; **P < 0Á01. Cell subsets involved in acute colitis under systemic IL-12 influence
Considering that the presence of mononuclear and polymorphonuclear cells in colonic tissue was different in the DSS and IL-12+DSS groups, we evaluated by flow cytometry blood and LP mononuclear subsets that could be involved in the inflammatory response. Figure 3(a) shows that mice with the double treatment presented a 2-to 2Á5-fold increment in CD4 + and CD8 + LP T cells, which was concurrent with the sharp reduction in blood (Fig. 3b) . However, most of the remaining CD4 + and CD8 + lymphocytes expressed the CCR5 receptor (Fig. 3b) , a marker of Th1 responses with an important role in localizing lymphocytes in the intestinal mucosa. 24 Changes in CD4 + and CD8 + T-cell subsets in the LP and blood were consistent with the increment of T cells bearing the a 4 b 7 integrin detected in MLN as early as day 5 (data not shown), as previously reported. 16 Considering that the CD11c + CD103 + dendritic cell (DC) subset has the unique ability to induce gut-homing receptors on MLN T lymphocytes, 25 we evaluated the frequency of CD11c + MHC-II + CD103 + DCs in MLN on day 5. Interestingly, on the same day, the IL-12 and IL-12+DSS groups showed a higher percentage of CD11c + MHC-II + CD103 + DCs, in marked contrast with DSS mice (Fig. 4b) . This increment could explain the expansion of activated a 4 b 7 + T cells ready to migrate to the LP. Taking into account that the strong Th1 milieu triggered by systemic IL-12 could be affecting the differentiation of monocytes arriving at the LP, 26 we evaluated CD11b + MHC-II + Ly6C + subsets in different groups. In agreement with the histopathological results, we found a significant increment of immature CD11b + MHC-II + Ly6C hi monocytes in the LP of IL-12+DSS mice (Fig. 5a) , which was coincident with the blood reduction in the CD11b + Ly6C hi subset (Fig. 5c) . On day 5, CD11b + Ly6C hi monocytes infiltrating the LP of DSS animals were mainly MHC-II negative (Fig. 5b) . In supernatants of colon explants from both groups with colitis we found an increment in MCP-1, a chemokine involved in recruiting immature Ly6C hi monocytes, 26 indicating that the rise was not elicited by IL-12 (data not shown). On the other hand, IL-12+DSS-treated animals showed a 3Á5-fold increase in IL-6 levels compared with the modest production of the DSS group (Fig. 5d) . This strong inflammatory response may be elicited by a higher supply of luminal stimuli because intestinal permeability is impaired as early as 3 days after the IL-12 injection. 16 To confirm that IL-12-primed cells instead of the cytokine storm were affecting inflammatory response, MLN cells from IL-12 cDNA-injected mice were isolated on day 7 and stimulated with rIL-12 before transfer into normal recipients that started DSS administration thereafter. As shown in the Supplementary material (Fig. S3a,b) , recipients presented a more pronounced weight loss and a higher DAI compared with the controls, indicating that IL-12-primed cells did exacerbate intestinal inflammation. We tried several strategies to purify MLN cells from IL-12-injected mice for further characterization. Yet, the recovery of few viable cells due to the higher fragility associated with the activation status 16, 18 precluded these experiments. The transference of MLN cells from normal donors stimulated with rIL-12 produced minor effects, demonstrating the relevance of the in vivo priming (data not shown).
Persistence of IL-12 priming
Finally, we wondered if cell priming could affect forthcoming intestinal inflammation. Hence, the mice were injected with IL-12 cDNA and again a week later, when cytokines regained baseline, 16 they were given DSS for 5 days. The IL-12+DSS mice developed a more severe colitis with early weight loss and higher DAI scores compared with the DSS group (Fig. 6a) To confirm the persistence of cell priming, a second group of mice started the DSS administration 60 days after the plasmid h.i. (Fig. 6b) . Again, IL-12+DSS mice developed a more severe colitis with early weight loss and higher DAI scores than the DSS group. Supernatants of colon explants showed similar levels of MCP-1 and IL-1b; however, 60 days after the IL-12 burst, a higher production of IFN-c was found in the IL-12+DSS group compared with the DSS mice (Fig. 6c) . Together, primed cells instead of cytokines were mediating the distinctive intestinal inflammation in mice under the IL-12+DSS treatment. The IL-12 priming was long-lasting and similar to findings shown in Fig. 2(m-p) and Fig. S1 (see Supplementary material). Mice developing colitis 60 days after h.i. presented a marked mononuclear infiltration in tissue and vessels and a higher histological score (see Supplementary material; Fig. S4 ).
Discussion
Our results show that, after systemic release of IL-12, mice developed a severe intestinal inflammation when they were exposed to luminal stimuli. This inflammatory response involved the activity of immune effector cells The combined IL-12+DSS treatment accelerated the clinical onset for 48 hr and the development of an inflammatory response with scarce polymorphonuclear infiltrate and reduced MPO activity, two features of acute DSS colitis. 4, 5 Also, a decrease of MPO in colitis has been reported after sustained IL-12 administration. 13 This reduction may be related to the selective increment of IL-10 in serum, MLN and the LP, given that inhaled IL-10 weakens lung MPO activity, thereby attenuating the pulmonary but not the systemic inflammatory response in a haemorrhagic shock model. 27 Our findings highlight that systemic IL-12 promotes severe colon inflammation in acute DSS colitis with deficient recruitment of neutrophils. Previous reports have shown that inflammatory lesions in DSS colitis contain lymphocytes and macrophages, producing IL-12 and other mediators beyond neutrophils. 28 In this study, the simultaneous exposure to IL-12 and DSS enabled a predominant mononuclear infiltrate as early as day 3, and a significant entry of T-cell subsets and immature monocytes into the LP on day 5.
Up-regulation of pro-inflammatory cytokines in inflammatory bowel disease leads to cell traffic in an organ-specific manner in response to adhesion molecules, chemokines and chemokine receptors. Accordingly, CD4 + T cells seem to take part in developing DSS-induced experimental colitis. 29 The localization within the intestinal mucosa is favoured by CCR5, 24 highly expressed in CD4 + and CD8 + subsets remaining in blood under our experimental conditions. Moreover, antibody depletion of CD8 + T lymphocytes in acute DSS colitis in C57BL/6 mice lessens severity and reduces production of IFN-c, TNF-a or IL-12 from LP cells. 30 In IFN-c À/À mice, clinical as well as histological scores are attenuated in DSS colitis, which proves the indispensable role of Th1 cytokines in this model. 31 Yet, identical histological features observed in BALB/c and SCID (lacking T and B cells) mice led to the alternative aetiological hypothesis that the acute DSS model is a predominantly macrophage-driven colitis. 28, 32 In fact, activated macrophages interacting with Th1 and Th2 cells seem to contribute to inflammation during the progression toward chronic forms of colitis. 32, 33 Indeed, we believe that this could be the scenario recreated by systemic IL-12 in less than 4 days.
Circulating Ly6C hi monocytes can give rise to all subsets of macrophages present in healthy and inflamed colon. Upon entry into the LP, monocytes differentiate in a 'waterfall' sequence from macrophages that down-modulate (i.e. Ly6C) or up-regulate (i.e. MHC-II, CD64, F4/ 80) several markers. 33 The process is driven by the environment where the exceptional exposure of the epithelium to the commensal flora causes tonic sustained lowgrade inflammation. 21, 26, 33 We found in this study that the systemic IL-12 burst affected LP replenishment in two ways: by speeding up the recruitment of Ly6C hi monocytes and stacking a particular pro-inflammatory subpopulation, as described in other experimental settings. because the differentiation sequence started 24-48 hr earlier, according to previous reports. 35, 36 In contrast, and at the same time, the LP of DSS mice displayed mostly Ly6C hi MHC-II À monocytes, i.e. newly arrived precursors. Selective accumulation of Ly6C hi monocyte-like cells in both groups with colitis may be explained by the ongoing colon inflammation that disrupts differentiation from LP macrophages. 21, 26, 35 Consistently, an infiltrating pro-inflammatory Ly6C hi MHC-II hi subset producing IL-12, IL-23, IL-6, TNF-a and inducible nitric oxide synthase dramatically accumulates in the LP from colitic mice. 26, 37 Still, early accumulation of Ly6C hi MHC-II hi equipped to interact with primed T cells could be a consequence of the sustained stimulation with IFN-c in colonic LP. 34, 38 Interestingly, when inflammation was limited to the DSS toxicity on the mucosal epithelium, the entry of this subset required at least 6 days. The systemic priming with IL-12, instead, dramatically accelerated the settlement of Ly6C hi MHC-II hi macrophage subpopulation by 3 days. The inflammatory characteristic of the predominant subset in IL-12+DSS mice could explain the robust IL-6 release, possibly elicited by luminal stimuli. In fact, as early as 3 days after IL-12 injection, paracellular permeability is altered, so favouring the supply of luminal stimuli that could support a premature and stronger inflammatory response. 16 Accordingly, Ly6C hi monocytes display a robust inflammatory signature with the expression of inducible nitric oxide synthase and IL-6, and exhibit uncontrolled reactivity to bacterial products upon entering the inflamed intestinal tissue. 21, 26 Considering that the decrease in colonic epithelial integrity even precedes histologically detectable colitis, 39 alteration in permeability in the IL-12+DSS-treated animals could even predate mononuclear recruitment.
Interestingly, these inflammatory macrophages cannot migrate to MLNs, thereby excluding their participation in the activation of naive T cells. 21 Due to their high MHC-II expression, however, they could potentially present antigens to resident or newly arrived T cells. In fact, incremented CD4 + and CD8 + T-cell subsets reaching the LP from IL-12+DSS mice could further enhance production of inflammatory mediators. 40 This subset could be intrinsically pro-inflammatory though, because Ly6C hi MHC-II hi cells sorted from the LP of wild-type mice induce a remarkable production of IFN-c by OT II T cells compared with other macrophages and DCs. 21 If with n = 4 or n = 5 mice per group. *P < 0Á05, **P < 0Á01; ***P < 0Á001 versus DSS mice. this is the case, then the IL-12 or other IL-12-induced molecules in our model could be selectively expanding this subset. These findings illustrate the cooperative overlap of two inflammatory scenarios in which systemic IL-12 and local IL-6 orchestrate the setting of acute colitis with unique traits.
Interactions between DCs and lymphocytes condition the subsequent immune response because DCs not only expand antigen-specific T cells but also determine the localization of effector lymphocytes. In this study, the progressive increment of T cells bearing the a 4 b 7 integrin in MLN and LP could be linked to the higher frequency of CD11c + CD103 + DCs in MLN, in agreement with the pivotal function of DCs in colonic inflammation. In fact, some authors claim that whereas neutrophils dominate the cellular infiltrate in the acute phase, monocytes/ macrophages dominate the infiltrate in the resolution phase of colitis and that conventional DCs are pivotal for the cellular switch that regulates this type of colonic inflammation. 41 Our findings emphasize that the switch occurs faster under the influence of systemic IL-12.
In this work, after triggering a transient and huge release of cytokines, we demonstrate that IL-12 priming was long-lasting and favoured a worsened outcome of acute colitis even 8 weeks later. In agreement with this finding, T cells are susceptible to the stimulating effect of IL-12 in a very narrow temporal window and the priming for IFN-c production can be maintained for several weeks. 37 Accordingly, explant cultures showed a significant release of IFN-c 60 days after priming. Moreover, the role of IL-12 in maintaining colitis is more complex than in promoting IFN-c production, acting also as a true growth stimulus for differentiated Th1 cells. 12 Colitogenic CD4 + memory T cells, which are capable of reproducing colitis, continuously circulate through the body and are involved in the persistence of inflammatory bowel disease. 42 Although we have not addressed these possibilities, primed T cells in IL-12+DSS mice recruited in inductive and effector intestinal sites could be further expanded, so precipitating stronger Th1 responses upon re-stimulation.
In summary, we demonstrated that systemic IL-12 in normal hosts is able to switch the progress of colitis to a predominant mononuclear inflammation. Primed T cells bearing homing receptors, pro-inflammatory macrophages and luminal antigens assemble together in LP quickly and, in this environment, IL-12 and IL-6 become pivotal molecules. Cells instead of cytokines mediate a more severe colitis with a long-lasting effect. Our findings become increasingly relevant because IL-12 is considered to be the cytokine that can redirect developing Th17 or regulatory T lymphocytes into potentially harmful inflammatory Th1 effector cells. 43 Also, this model provides an opportunity to study the pathogenesis of this inflammatory disease and, more broadly, to understand the influence of systemic signals in mucosal surfaces.
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